Cargando…

High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion

BACKGROUND: NUCB2, a novel multifunctional protein containing several functional domains, was newly found to play important roles in many cancers, but its role in papillary thyroid cancer (PTC) is not well investigated. Therefore, our study was performed to explore the functions of NUCB2 in PTC. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jingzhu, Yun, Xinwei, Ruan, Xianhui, Chi, Jiadong, Yu, Yang, Li, Yigong, Zheng, Xiangqian, Gao, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388962/ https://www.ncbi.nlm.nih.gov/pubmed/30863097 http://dx.doi.org/10.2147/OTT.S184560

Ejemplares similares

TET3 Mediates 5hmC Level and Promotes Tumorigenesis by Activating AMPK Pathway in Papillary Thyroid Cancer
por: Chi, Jiadong, et al.
Publicado: (2022)

Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles
por: Wei, Songfeng, et al.
Publicado: (2019)

Integrated microRNA-mRNA analyses of distinct expression profiles in follicular thyroid tumors
por: Chi, Jiadong, et al.
Publicado: (2017)

Ultrasound features of medullary thyroid cancer as predictors of biological behavior
por: Zhao, Jingzhu, et al.
Publicado: (2021)

Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma
por: Gu, Pengfei, et al.
Publicado: (2022)

LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma
por: Hou, Xiukun, et al.
Publicado: (2021)

Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases
por: Zhi, Jingtai, et al.
Publicado: (2017)

To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments
por: Sun, Ying, et al.
Publicado: (2022)

Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients
por: Zheng, Xiangqian, et al.
Publicado: (2019)

Relationship Between Thyroid Autoantibodies and Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents
por: Huang, Dongmei, et al.
Publicado: (2022)

Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway
por: Meng, Xiangrui, et al.
Publicado: (2020)

NUCB-2/Nesfatin-1 promotes the proliferation of nasopharyngeal carcinoma cells
por: Liang, Yunlai, et al.
Publicado: (2023)

The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification
por: Yi, Jiaoyu, et al.
Publicado: (2021)

PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause
por: Hou, Xiukun, et al.
Publicado: (2023)

Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature
por: Li, Qiang, et al.
Publicado: (2023)

Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer
por: Hao, Weijing, et al.
Publicado: (2023)

Consistent analysis of differentially expressed genes across 7 cell types in papillary thyroid carcinoma
por: Ruan, Xianhui, et al.
Publicado: (2023)

BRAF(V600E) status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China
por: Zheng, Xiangqian, et al.
Publicado: (2012)

Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects
por: Gu, Pengfei, et al.
Publicado: (2022)

Aurora kinase a promotes the progression of papillary thyroid carcinoma by activating the mTORC2-AKT signalling pathway
por: Zhao, Zewei, et al.
Publicado: (2022)

Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer
por: Zeng, Yu, et al.
Publicado: (2023)

Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer
por: Zhang, Hongtuan, et al.
Publicado: (2013)

Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib
por: Hu, Linfei, et al.
Publicado: (2022)

CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer
por: Xia, Erjie, et al.
Publicado: (2018)

Active surveillance as a management strategy for papillary thyroid microcarcinoma
por: Zhang, Huan, et al.
Publicado: (2020)

Diagnosis and treatment of ectopic thyroid carcinoma: A case report and literature review
por: Fu, Guiming, et al.
Publicado: (2022)

Inhibition of NUCB2 suppresses the proliferation, migration, and invasion of rheumatoid arthritis synovial fibroblasts from patients with rheumatoid arthritis in vitro
por: Zhang, Shuo, et al.
Publicado: (2022)

Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer
por: Ma, Weike, et al.
Publicado: (2023)

Expression of NUCB2/NESF-1 in Breast Cancer Cells
por: Kmiecik, Alicja, et al.
Publicado: (2022)

Expression and correlation of COX-2 and NUCB1 in colorectal adenocarcinoma
por: Zhang, Yuanyuan, et al.
Publicado: (2023)

The LINC01186 suppresses cell proliferation and invasion ability in papillary thyroid carcinoma
por: Wang, Nanpeng, et al.
Publicado: (2018)

LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in papillary thyroid carcinoma
por: Shen, Yanyan, et al.
Publicado: (2018)

NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT
por: Hao, Ru-Tian, et al.
Publicado: (2019)

The Tissue Distribution of Nesfatin-1/NUCB2 in Mouse
por: Kim, Jinhee, et al.
Publicado: (2014)

LINC00511 promotes melanoma progression by targeting miR-610/NUCB2
por: Zhang, Guangjing, et al.
Publicado: (2023)

Clinical significance of NUCB2 mRNA expression in prostate cancer
por: Zhang, Hongtuan, et al.
Publicado: (2013)

Expression of Nesfatin-1/NUCB2 in Fetal, Neonatal and Adult Mice
por: Chung, Yiwa, et al.
Publicado: (2013)

High NUCB2 expression level is associated with metastasis and may promote tumor progression in colorectal cancer
por: Xie, Jun, et al.
Publicado: (2018)

TRPC5 expression promotes the proliferation and invasion of papillary thyroid carcinoma through the HIF-1α/Twist pathway
por: Yang, Jing, et al.
Publicado: (2023)

ANGPTL4 Promotes the Proliferation of Papillary Thyroid Cancer via AKT Pathway
por: Yang, Longyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hos7rtn5t189ajtp2ieolt5r17